Literature DB >> 621821

Carcinoma in situ of the urethra associated with bladder carcinoma: the role of urethrectomy.

J P Richie, D G Skinner.   

Abstract

Carcinoma in situ of the urethral margin was demonstrated in 12 men who underwent radical cystectomy for bladder cancer. Six of the 7 patients who underwent simultaneous urethrectomy are free of the tumor but 4 of the 5 who did not undergo urethrectomy died of the disease. This dismal survival rate for patients with carcinoma in situ in the retained urethra indicates the necessity for clear-cut guide lines for the performance of urethrectomy. Frozen section of the urethral margin, as well as of both distal ureters, should be obtained at the time of operation, and urethrectomy, either simultaneous or during the same hospitalization, should be considered strongly for those with carcinoma in situ of the bladder neck or of the urethra.

Entities:  

Mesh:

Year:  1978        PMID: 621821     DOI: 10.1016/s0022-5347(17)57389-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Pathologic guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature.

Authors:  Simon D Wu; Vannita Simma-Chang; John P Stein
Journal:  Rev Urol       Date:  2006

2.  Incidence of urethral tumor involvement in 910 men with bladder cancer.

Authors:  M Erckert; A Stenzl; M Falk; G Bartsch
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 3.  The use of neobladders in women undergoing cystectomy for transitional-cell cancer.

Authors:  A Stenzl; K Colleselli; S Poisel; H Feichtinger; G Bartsch
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  Orthotopic urinary diversion: the Kock ileal neobladder.

Authors:  D A Elmajian; J P Stein; D G Skinner
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 5.  Orthotopic neobladder after cystectomy for bladder cancer.

Authors:  Tadao Kakizoe
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.